J Frontier Co

J Frontier Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of J Frontier Co (2934.T) as of Oct 23, 2026 is 3.23 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 3.20 % — a change of 1.01% (higher).

EBIT/Assets

3.23 %

YoY

1.01%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of J Frontier Co is 2026 3.23 % . Operating Income to Assets Ratio (EBIT/Assets) of J Frontier Co was 2025 3.20 % . It decreases by 1.01% higher compared to the previous year.

The J Frontier Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
19.28 JPY
Jan 1, 2020
8.38 JPY
Jan 1, 2021
25.90 JPY
Jan 1, 2022
11.98 JPY
Jan 1, 2023
-25.04 JPY
Jan 1, 2024
-4.85 JPY
Jan 1, 2025
3.20 JPY
Jan 1, 2026
3.23 JPY
The J Frontier Co EBIT/Assets history
YEAREBIT/AssetsYoY
3.23 %+1.01%
3.20 %-166.09%
-4.85 %-80.65%
-25.04 %-309.09%
11.98 %-53.75%
25.90 %+208.90%
8.38 %-56.52%
19.28 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

J Frontier Co Stock analysis

What does J Frontier Co do? J Frontier Co., Ltd. generates revenue through three business segments. The Healthcare Sales segment sells health foods and cosmetics, including the 328 selection series of fermented hydrogen, via mail-order. The Medical Care Sales segment operates dispensing pharmacies and offers mail-order services for ethical drugs, alongside the Why Pure series and Chinese herbs. The Health Care Marketing segment provides advertising agency services, sales promotion support, and wholesale of in-house products for healthcare brands. The company's primary customers are consumers purchasing health foods, cosmetics, and pharmaceuticals through mail-order channels. Pharmacies and healthcare product distributors also buy services from the Health Care Marketing segment for advertising and sales support. The firm's brands include 328 selection, Why Pure, and Chinese herbs, which are sold directly or through marketing partnerships. J Frontier's revenue streams are driven by direct sales of its branded products, mail-order distribution of health and medical goods, and marketing services for healthcare brands. The company targets health-conscious consumers and healthcare businesses seeking promotional support and product distribution. J Frontier Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about J Frontier Co stock

Operating Income to Assets Ratio (EBIT/Assets) of J Frontier Co is 3.23 % in 2026.

Operating Income to Assets Ratio (EBIT/Assets) of J Frontier Co changed from 3.20 % to 3.23 %, representing a 1.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) J Frontier Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s J Frontier Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — J Frontier Co

All Key Metrics — J Frontier Co